On the stock market since 2013, it operates in the world of health and science. It has 6,442 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 8% a year over the last 4 years. Every year shown ended in profit.
The gap is $172.7M. In times of high interest rates, a gap like that can squeeze a company.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
It pays out $1.66 per share each year — regular cash for whoever holds the stock.
The weight of investors positioned for a fall can be felt in the market.
On our five-subject report card, VRBCF sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: VRBCF is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.